These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 30826057)

  • 1. Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses.
    Tamada K; Nakajima S; Ogawa N; Inada M; Shibasaki H; Sato A; Takasawa R; Yoshimori A; Suzuki Y; Watanabe N; Oyama T; Abe H; Inoue S; Abe T; Yokomizo T; Tanuma S
    Biochem Biophys Res Commun; 2019 Apr; 511(3):665-670. PubMed ID: 30826057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
    Nakajima S; Ogawa N; Yokoue N; Tachibana H; Tamada K; Okazawa M; Sato A; Oyama T; Abe H; Kamiya T; Yoshimori A; Yoshizawa K; Inoue S; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1155-1161. PubMed ID: 33041002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
    Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
    Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
    Li K; Yang J; Han X
    Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model.
    Valdés-Ferrer SI; Rosas-Ballina M; Olofsson PS; Lu B; Dancho ME; Li J; Yang H; Pavlov VA; Chavan SS; Tracey KJ
    Shock; 2013 Dec; 40(6):492-5. PubMed ID: 24089009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway.
    He J; Qin W; Jiang S; Lin Y; Lin Y; Yang R; Xu M; Liu Q
    Drug Dev Res; 2024 Jun; 85(4):e22219. PubMed ID: 38845211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icariin and icaritin ameliorated hippocampus neuroinflammation via inhibiting HMGB1-related pro-inflammatory signals in lipopolysaccharide-induced inflammation model in C57BL/6 J mice.
    Liu L; Zhao Z; Lu L; Liu J; Sun J; Wu X; Dong J
    Int Immunopharmacol; 2019 Mar; 68():95-105. PubMed ID: 30616172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
    Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
    J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effects of a non-narcotic opium alkaloid medicine, papaverine, in human glioblastoma cells.
    Inada M; Shindo M; Kobayashi K; Sato A; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
    PLoS One; 2019; 14(5):e0216358. PubMed ID: 31100066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth.
    Inada M; Sato A; Shindo M; Yamamoto Y; Akasaki Y; Ichimura K; Tanuma SI
    Anticancer Res; 2019 Dec; 39(12):6743-6750. PubMed ID: 31810939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
    Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibiting HMGB1-RAGE axis prevents pro-inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury.
    Fan H; Tang HB; Chen Z; Wang HQ; Zhang L; Jiang Y; Li T; Yang CF; Wang XY; Li X; Wu SX; Zhang GL
    J Neuroinflammation; 2020 Oct; 17(1):295. PubMed ID: 33036632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain.
    Yoshizawa K; Takeuchi K; Nakamura T; Ukai S; Takahashi Y; Sato A; Takasawa R; Tanuma SI
    Synapse; 2021 Mar; 75(3):e22188. PubMed ID: 32979223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
    Good DW; George T; Watts BA
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indoprofen exerts a potent therapeutic effect against sepsis by alleviating high mobility group box 1-mediated inflammatory responses.
    Bi X; Yan X; Jiang B; Liang J; Zhou J; Lu S; Liu J; Luo L; Yin Z
    Toxicol Appl Pharmacol; 2021 Dec; 433():115778. PubMed ID: 34755645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages.
    Ogawa N; Nakajima S; Tamada K; Yokoue N; Tachibana H; Okazawa M; Oyama T; Abe H; Yamazaki H; Yoshimori A; Sato A; Kamiya T; Yokomizo T; Uchiumi F; Abe T; Tanuma SI
    Arch Biochem Biophys; 2021 Oct; 711():109029. PubMed ID: 34517011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs.
    Behl T; Sharma E; Sehgal A; Kaur I; Kumar A; Arora R; Pal G; Kakkar M; Kumar R; Bungau S
    Mol Biol Rep; 2021 Feb; 48(2):1869-1881. PubMed ID: 33479829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of lycopene on HMGB1-mediated pro-inflammatory responses in both cellular and animal models.
    Lee W; Ku SK; Bae JW; Bae JS
    Food Chem Toxicol; 2012 Jun; 50(6):1826-33. PubMed ID: 22429818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.